GMR Solutions Inc. (GMRS) Stock Score, Valuation & Financial Research

GMR Solutions Inc. is in the Healthcare sector and Medical - Care Facilities industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for GMRS

GMR Solutions Inc. does not currently have a complete Wall Street Score. The stored market price is USD 10.20. These figures are a research snapshot, not a buy or sell recommendation.

What GMR Solutions Inc. does

GMR Solutions Inc., headquartered in Lewisville, Texas, is a leading U.S.-based company specializing in comprehensive out-of-hospital healthcare and mobile clinical services. The organization delivers both emergency and non-emergency medical care. Beyond direct patient transport and treatment, their service portfolio extends to include tailored membership programs, dedicated standby medical support for special events, and significant contractual agreements. These include a national ambulance contract with the Federal Emergency Management Agency (FEMA), as well as numerous partnerships with state agencies and health systems, all aimed at streamlining emergency medical response efforts. GMR Solutions serves a diverse client base, encompassing hospital systems of all sizes (from large regional networks to smaller independent facilities), local communities, healthcare payors, public health organizations, and various governmental entities at local, state, and federal levels.

Company business and revenue

Research reporting period: 2025-12-31. A research update is not a new financial filing.

How the company makes money

GMR Solutions Inc. operates as a provider of emergency medical services, disaster response, and mobile clinical practice groups. The company generates revenue primarily through service fees charged to patients, insurance providers, and government entities for emergency and non-emergency medical transportation and out-of-hospital clinical care.

Products and services

  • Emergency medical services (EMS), non-emergency medical transportation, disaster response services, and mobile clinical practice groups.

Customer types

Government entities; Insurance providers; Individual patients.

Suppliers, materials and equipment

  • Medical equipment and vehicle manufacturers — Suppliers of ambulances, medical devices, and clinical supplies required for emergency medical operations. Source

Business strengths to evaluate

  • Nation's largest provider of emergency medical services Source

Business risks and research considerations

  • High leverage and debt obligations Source

Sources: Company research source · Nation's largest provider of emergency medical services · High leverage and debt obligations

Company research refreshed 2026-10-12. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

GMRS financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 10.20
Market capitalization:
550.92M (currency not supplied)
Revenue:
USD 5.74B
Net income:
USD 206.23M
Free cash flow:
USD 382.6M
Cash:
USD 496.76M
Total debt:
USD 4.75B
EPS:
USD 0.16
P/E ratio:
63.7x

What stands out

  • Free cash flow is USD 382.6M, positive for the stored period.
  • The balance sheet shows USD 496.76M of cash versus USD 4.75B of total debt, with debt exceeding cash on these two reported measures.
  • The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Free cash flow is 6.7% of stored revenue. This is a simple cross-field ratio, not a verified same-period cash conversion margin; confirm reporting periods before comparison.
  • Net income equals 3.6% of stored revenue. This is an indicative ratio only; accounting periods and units should be verified in filings.
  • Debt exceeds cash by USD 4.26B using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for GMRS

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • Is GMRS's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • Is GMRS's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • What does the current share basis reconciled warning mean for the reliability or interpretation of GMRS's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 55% of the scoring inputs required for this public page are currently available.

How to research GMRS

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.